(Q35000129)

5 August 2017

title

Discontinued psychiatric drugs in 2008. (English)

1 reference

5 August 2017

Joanna K Soczynska

3

0 references

Roger S McIntyre

series ordinal

5

object named as

Roger S McIntyre

1 reference

5 August 2017

Victoria D Kirchhoff

1

1 reference

5 August 2017

Ha T T Nguyen

series ordinal

2

1 reference

5 August 2017

Hanna Woldeyohannes

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Expert Opinion on Investigational Drugs

5 August 2017

published in

1 reference

5 August 2017

volume

18

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

1431-1443

1 reference

Results of phase 3 of the CATIE schizophrenia trial

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

Pharmacokinetics of licarbazepine in healthy volunteers: single and multiple oral doses and effect of food

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903184591

10.1517/13543780903184591

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference